MedPlus Health Services Board meeting scheduled on May 29, 2026 to approve audited standalone and consolidated financial results.
Results pertain to Q4 and full financial year ended March 31, 2026; filing under Regulation 29 read with Regulation 33 of SEBI LODR.
Trading window for Designated Persons closed from April 1, 2026 to May 31, 2026 under SEBI Insider Trading Regulations.